H Schneid

1.2k total citations
27 papers, 977 citations indexed

About

H Schneid is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, H Schneid has authored 27 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in H Schneid's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Genetic Syndromes and Imprinting (6 papers) and Inflammatory mediators and NSAID effects (6 papers). H Schneid is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Genetic Syndromes and Imprinting (6 papers) and Inflammatory mediators and NSAID effects (6 papers). H Schneid collaborates with scholars based in France, United Kingdom and Austria. H Schneid's co-authors include Yves Le Bouc, Nicholas Moore, Éric Van Ganse, F Girard, Wolf Reik, Wendy A. Bickmore, Keith Brown, Eamonn R. Maher, Christine Gicquel and Ronald Wall and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

H Schneid

26 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Schneid France 17 393 356 232 226 204 27 977
Christian Hengstenberg Germany 20 367 0.9× 173 0.5× 216 0.9× 45 0.2× 53 0.3× 37 1.1k
Anja Rudolph Germany 17 360 0.9× 199 0.6× 120 0.5× 119 0.5× 24 0.1× 28 1000
Marcelo R. Luizon Brazil 23 291 0.7× 115 0.3× 83 0.4× 271 1.2× 32 0.2× 86 1.3k
Gregory B. Holmes United States 13 441 1.1× 61 0.2× 90 0.4× 283 1.3× 141 0.7× 18 1.2k
N Islam United States 13 219 0.6× 65 0.2× 162 0.7× 53 0.2× 138 0.7× 18 1.3k
Vaiva Lesauskaitė Lithuania 18 246 0.6× 137 0.4× 193 0.8× 41 0.2× 37 0.2× 91 1.0k
Susan Loftus United States 6 89 0.2× 89 0.3× 214 0.9× 44 0.2× 243 1.2× 10 579
B Kattman United States 9 207 0.5× 179 0.5× 50 0.2× 77 0.3× 66 0.3× 25 676
John Kemp United Kingdom 14 109 0.3× 208 0.6× 47 0.2× 47 0.2× 65 0.3× 23 652

Countries citing papers authored by H Schneid

Since Specialization
Citations

This map shows the geographic impact of H Schneid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Schneid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Schneid more than expected).

Fields of papers citing papers by H Schneid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Schneid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Schneid. The network helps show where H Schneid may publish in the future.

Co-authorship network of co-authors of H Schneid

This figure shows the co-authorship network connecting the top 25 collaborators of H Schneid. A scholar is included among the top collaborators of H Schneid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Schneid. H Schneid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Andrew, Ulrich R. Kleeberg, Sebastiano Mercadante, et al.. (2015). Improved patient functioning after treatment of breakthrough cancer pain: an open-label study of fentanyl buccal tablet in patients with cancer pain. Supportive Care in Cancer. 23(7). 2135–2143. 8 indexed citations
2.
Moore, Nicholas, et al.. (2012). A review of the pharmacokinetic profile of transmucosal fentanyl formulations. Current Medical Research and Opinion. 28(11). 1781–1790. 13 indexed citations
3.
Ganse, Éric Van, Judith K. Jones, Nicholas Moore, et al.. (2005). A large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data. Pharmacoepidemiology and Drug Safety. 14(4). 249–255. 12 indexed citations
4.
5.
Moore, Nicholas, Andrew Charlesworth, Éric Van Ganse, et al.. (2003). Risk factors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiology and Drug Safety. 12(7). 601–610. 41 indexed citations
6.
7.
Rampal, Patrick, Nicholas Moore, Éric Van Ganse, et al.. (2002). Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-Counter Doses. Journal of International Medical Research. 30(3). 301–308. 34 indexed citations
8.
Schneid, H, M.-P. Vazquez, C. Vacher, et al.. (1997). The Beckwith-Wiedemann syndrome phenotype and the risk of cancer. Medical and Pediatric Oncology. 28(6). 411–415. 37 indexed citations
9.
Reik, Wolf, Keith Brown, H Schneid, et al.. (1995). Imprinting mutations in the Beckwith—Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2–H19 domain. Human Molecular Genetics. 4(12). 2379–2385. 182 indexed citations
10.
Gicquel, Christine, Xavier Bertagna, H Schneid, et al.. (1994). Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.. The Journal of Clinical Endocrinology & Metabolism. 78(6). 1444–1453. 168 indexed citations
11.
Schneid, H, P. Elly Holthuizen, & J.S. Sussenbach. (1993). Differential promoter activation in two human insulin-like growth factor-II-producing tumor cell lines.. Endocrinology. 132(3). 1145–1150. 16 indexed citations
12.
Boulle, Nathalie, H Schneid, Anne Listrat, et al.. (1993). Developmental regulation of bovine insulin-like growth factor-II (IGF-II) gene expression: homology between bovine transcripts and human IGF-II exons. Journal of Molecular Endocrinology. 11(2). 117–128. 11 indexed citations
13.
Schneid, H, Danielle Seurin, M.-P. Vazquez, et al.. (1993). Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome.. Journal of Medical Genetics. 30(5). 353–362. 61 indexed citations
14.
Gicquel, Christine, S Cabrol, H Schneid, F Girard, & Yves Le Bouc. (1992). Molecular diagnosis of Turner's syndrome.. Journal of Medical Genetics. 29(8). 547–551. 23 indexed citations
15.
Loret, Camille, Thierry Janet, G. Labourdette, H Schneid, & M Binoux. (1991). FGFs stimulate IGF binding protein synthesis without affecting IGF synthesis in rat astroblasts in primary culture. Glia. 4(4). 378–383. 17 indexed citations
16.
Schneid, H, M.-P. Vazquez, Danielle Seurin, & Yves Le Bouc. (1991). Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome.. PubMed. 1(4). 168–70. 16 indexed citations
17.
Schneid, H, Yves Le Bouc, Danielle Seurin, et al.. (1990). Insulin-Like Growth Factor-I Gene Analysis in Subjects with Constitutionally Variant Stature. Pediatric Research. 27(5). 488–491. 16 indexed citations
18.
Schneid, H, F Girard, M Binoux, & Yves Le Bouc. (1989). Ava ll RFLP at the insulin-like growth factor ll (IGF 11) locus on chromosome 11. Nucleic Acids Research. 17(1). 466–466. 7 indexed citations
19.
Schneid, H, et al.. (1988). Eco RV RFLP at the insulin-like growth factor I (IGF I) locus on chromosome 12. Nucleic Acids Research. 16(18). 9059–9059. 5 indexed citations
20.
Schneid, H, Yves Le Bouc, M Gourmelen, et al.. (1988). 105 RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP) OF THE INSULIN-LIKE GROWTH FACTOR 1 (1GF 1) GENE IN FRENCH SUBJECTS. Pediatric Research. 24(4). 534–534. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Hengstenberg Breakdown of academic impact, for papers by Anja Rudolph Breakdown of academic impact, for papers by Marcelo R. Luizon Breakdown of academic impact, for papers by Gregory B. Holmes Breakdown of academic impact, for papers by N Islam Breakdown of academic impact, for papers by Vaiva Lesauskaitė Breakdown of academic impact, for papers by Susan Loftus Breakdown of academic impact, for papers by B Kattman Breakdown of academic impact, for papers by John Kemp
Rankless by CCL
2026